Bo-Ju Pan Selected Research

Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)

3/2023	Correction: Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis.
1/2022	Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo-Ju Pan Research Topics

Disease

2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 03/2023 - 01/2022
1	Castleman Disease (Castleman's Disease) 01/2023
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2023
1	acquired Thrombotic thrombocytopenic purpura 01/2020
1	Cholangiocarcinoma 01/2020
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2019
1	Inflammation (Inflammations) 11/2019
1	Neoplasms (Cancer) 10/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2016

Drug/Important Bio-Agent (IBA)

2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2023 - 01/2022
2	Thalidomide (Thalomid)FDA Link 03/2023 - 01/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2023 - 01/2022
1	Bortezomib (Velcade)FDA Link 01/2023
1	ThrombospondinsIBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	AutoantibodiesIBA 01/2020
1	DisintegrinsIBA 01/2020
1	SteroidsIBA 11/2019
1	G-Protein-Coupled Receptor Kinase 2IBA 10/2016

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2019